Abbott (NYSE: ABT) recently launched a smartphone app that works with both its FreeStyle Libre 2 and FreeStyle Libre 3 continuous glucose monitoring systems. “By listening to our customers, we developed a universal app with enhanced features to make living with diabetes easier,” Badia Boudaiffa, VP of North America commercial operations for Abbott’s diabetes care […]
Diabetes
Medtronic wins FDA nod for new Simplera Sync CGM with MiniMed 780G
Medtronic (NYSE:MDT) announced that the FDA approved its Simplera Sync continuous glucose monitor for use with the MiniMed 780G. Approval provides more options for users of the automated insulin delivery (AID) system, which can also work with the Guardian 4 sensor. Simplera Sync, a disposable, all-in-one sensor requires no fingersticks or overtape. It works with SmartGuard […]
Tidepool achieves new certification for open-source quality management system
Tidepool announced today that it secured a new certification for its open-source quality management system, known as qmsOS. Palo Alto, California-based Tidepool, a non-profit diabetes data management group, develops open-source technology for the diabetes community. That includes the FDA-cleared Tidepool Loop, a “do-it-yourself” (DIY) automated insulin delivery (AID) system. Recent collaborations include integrations with Abbott and Sequel […]
Glucotrack to bring implantable CBGM to automated insulin delivery system initiative in Europe
Glucotrack (Nasdaq:GCTK) announced today that it intends to participate in a bionic pancreas initiative in Europe. FORGETDIABETES aims to develop a long-term automated insulin delivery system. This system should enable optimal glucose control without patient intervention. The initiative, funded by the European Union’s Horizon 2020 research and innovation program, offers support from basic research to […]
Tidepool founder and CEO is stepping down
Howard Look announced that he is stepping down from his role as CEO at automated insulin delivery technology developer Tidepool. Look, who co-founded the Palo Alto, California-based company in 2013, shared the news on LinkedIn. “After 12 incredible years, I’m stepping back from my role as CEO of Tidepool,” he wrote. “It’s hard to put […]
Dexcom wins FDA nod for 15-day CGM
Dexcom (Nadsaq:DXCM) announced today that the FDA cleared its G7 15-day continuous glucose monitoring (CGM) system. The clearance covers people over the age of 18 years old in the U.S. It makes the G7, Dexcom’s latest-generation CGM, the longest-lasting wearable CGM, according to the company. San Diego–based Dexcom submitted its 15-day G7 CGM to the […]
Doctors issue call to action to eliminate barriers to automated insulin delivery
Key opinion leaders issued a call to action to the diabetes community to recognize the importance of automated insulin delivery (AID). A number of doctors issued this call, published by Mary Ann Liebert’s Diabetes Technology & Therapeutics, to implement the advances made in the AID technology space. They say pivotal trials and real-world data support […]
Vaxess raises $9M to support drug delivery patch, GLP-1 work
Shelf-stable vaccine patch maker Vaxess Technologies announced today that it received an additional $9 million in funding. Participants in the latest funding round for Woburn, Massachusetts-based Vaxess included RA Capital Management and Engine Ventures. The company plans to use the funds to continue to advance its work in GLP-1 therapeutics and to expand manufacturing capabilities. It […]
Medtronic has a new leader in its Diabetes unit
Medtronic (NYSE:MDT) has appointed a former Dexcom leader as the new head of Americas for its Diabetes business unit. On LinkedIn, Laura Endres said in a post that last week was her first with the medtech giant’s Diabetes unit. She spent more than a decade at continuous glucose monitor (CGM) maker Dexcom, bringing significant diabetes […]
Insulet launches Omnipod 5 in Canada
Insulet (Nasdaq:PODD) announced today that it commercially launched the Omnipod 5 automated insulin delivery (AID) system in Canada. The first tubeless, waterproof AID system is approved in Canada for people with type 1 diabetes ages two years and above. In Canada, it pairs with the Dexcom G6 and G7 continuous glucose monitor (CGM) systems to […]
